• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过药物共递药和原位血管促进策略增强肿瘤治疗。

Enhanced tumor therapy via drug co-delivery and in situ vascular-promoting strategy.

机构信息

Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China; Department of Pharmacy, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan 430030, China.

Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China; National Engineering Research Centre for Nanomedicine, Huazhong University of Science and Technology, Wuhan 430030, China.

出版信息

J Control Release. 2017 Jul 28;258:108-120. doi: 10.1016/j.jconrel.2017.05.016. Epub 2017 May 15.

DOI:10.1016/j.jconrel.2017.05.016
PMID:28522191
Abstract

Conventional tumor starving therapy by reducing its vessel density may be effective at early treatment but potentially contributes to tumor hypoxia, drug resistance and metastasis. A new strategy through enhancing tumor angiogenesis in combination with effective chemotherapeutic drugs, has shown successful tumor growth and spread inhibition. To achieve in situ release of angiogenic and antitumor drugs in tumor, we designed a precise ratiometric polymeric hybrid micelle system for co-delivering nitric oxide and paclitaxel. The hybrid micelles could accumulate in tumor via the long blood circulation and enhanced permeability and retention (EPR) effect, promote the drug accumulation and penetration in tumor by in situ increased vascular permeability, blood perfusion and vessel density, achieve the synergistic antitumor effect of nitric oxide and paclitaxel through modified tumor microenvironment, overcome multidrug resistance and inhibit metastasis. This study presents a combinational therapy against tumor progression and spread, which shows great potential in cancer therapy of the future.

摘要

传统的肿瘤饥饿疗法通过降低其血管密度可能在早期治疗中有效,但可能导致肿瘤缺氧、耐药性和转移。一种新的策略是通过增强肿瘤血管生成并结合有效的化疗药物,已显示出成功抑制肿瘤生长和扩散。为了在肿瘤中实现血管生成和抗肿瘤药物的原位释放,我们设计了一种精确的比例聚合物杂化胶束系统,用于共递送一氧化氮和紫杉醇。该杂化胶束可以通过长循环和增强的通透性和保留(EPR)效应在肿瘤中积累,通过原位增加血管通透性、血液灌注和血管密度促进药物在肿瘤中的积累和渗透,通过改变肿瘤微环境实现一氧化氮和紫杉醇的协同抗肿瘤作用,克服多药耐药性并抑制转移。这项研究提出了一种针对肿瘤进展和扩散的联合治疗方法,在未来的癌症治疗中具有很大的潜力。

相似文献

1
Enhanced tumor therapy via drug co-delivery and in situ vascular-promoting strategy.通过药物共递药和原位血管促进策略增强肿瘤治疗。
J Control Release. 2017 Jul 28;258:108-120. doi: 10.1016/j.jconrel.2017.05.016. Epub 2017 May 15.
2
CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels.载姜黄素介孔硅纳米粒双重靶向给药系统治疗肿瘤及血管新生
Biomaterials. 2013 Dec;34(37):9496-508. doi: 10.1016/j.biomaterials.2013.09.001. Epub 2013 Sep 17.
3
Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy.用于吸入式抗癌化疗的耐受性良好且可穿透肿瘤的基于聚合物胶束的干粉剂的研发与评估。
Int J Pharm. 2016 Mar 30;501(1-2):148-59. doi: 10.1016/j.ijpharm.2016.01.073. Epub 2016 Feb 2.
4
Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.利用 S-亚硝基化人血清白蛋白二聚体增强 EPR 效应和白蛋白-蛋白相互作用提高白蛋白结合紫杉醇纳米粒的抗癌效果。
Biomaterials. 2017 Sep;140:162-169. doi: 10.1016/j.biomaterials.2017.06.021. Epub 2017 Jun 22.
5
In vitro and in vivo evaluation of APRPG-modified angiogenic vessel targeting micelles for anticancer therapy.用于抗癌治疗的APRPG修饰的血管生成靶向胶束的体外和体内评价
Int J Pharm. 2015;486(1-2):356-66. doi: 10.1016/j.ijpharm.2015.03.067. Epub 2015 Apr 1.
6
Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.重构高密度脂蛋白介导的HZ08和紫杉醇靶向共递送增强了紫杉醇对多药耐药MCF-7乳腺癌细胞的疗效。
Eur J Pharm Sci. 2016 Sep 20;92:11-21. doi: 10.1016/j.ejps.2016.06.017. Epub 2016 Jun 23.
7
A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.一种安全、简单、高效的阿霉素前药杂化胶束,用于克服肿瘤多药耐药性和靶向递药。
J Control Release. 2016 Aug 10;235:182-194. doi: 10.1016/j.jconrel.2016.06.003. Epub 2016 Jun 2.
8
In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.载紫杉醇靶向壳聚糖基聚合物胶束的体内药代动力学、生物分布及抑瘤作用。
Drug Deliv. 2016 Jun;23(5):1707-17. doi: 10.3109/10717544.2014.954281. Epub 2014 Sep 4.
9
A Novel Paclitaxel-Loaded Polymeric Micelle System with Favorable Biocompatibility and Superior Antitumor Activity.一种具有良好生物相容性和卓越抗肿瘤活性的新型载紫杉醇聚合物胶束系统。
Anticancer Res. 2018 Jan;38(1):219-225. doi: 10.21873/anticanres.12211.
10
Suppress orthotopic colon cancer and its metastasis through exact targeting and highly selective drug release by a smart nanomicelle.通过智能纳米胶束的精确靶向和高选择性药物释放抑制原位结肠癌及其转移。
Biomaterials. 2018 Apr;161:144-153. doi: 10.1016/j.biomaterials.2018.01.043. Epub 2018 Feb 2.

引用本文的文献

1
Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies.解码肿瘤血管生成:抗癌策略中的途径、机制及未来方向
Biomark Res. 2025 Apr 18;13(1):62. doi: 10.1186/s40364-025-00779-x.
2
Targeted Hybrid Nanocarriers as Co-Delivery Systems for Enhanced Cancer Therapy.靶向杂化纳米载体作为增强癌症治疗的共递送系统
Adv Pharm Bull. 2024 Oct;14(3):558-573. doi: 10.34172/apb.2024.046. Epub 2024 May 15.
3
Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies.用于癌症治疗的智能运载工具:类别、独特作用及治疗策略
Nanoscale Adv. 2024 Jun 20;6(17):4275-4308. doi: 10.1039/d4na00285g. eCollection 2024 Aug 20.
4
Enhancing Cellular Uptake of Native Proteins through Bio-Orthogonal Conjugation with Chemically Synthesized Cell-Penetrating Peptides.通过与化学合成的细胞穿透肽进行生物正交共轭增强天然蛋白质的细胞摄取。
Pharmaceutics. 2024 May 3;16(5):617. doi: 10.3390/pharmaceutics16050617.
5
Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications.一氧化氮:生理功能、传递和生物医学应用。
Adv Sci (Weinh). 2023 Oct;10(30):e2303259. doi: 10.1002/advs.202303259. Epub 2023 Aug 26.
6
The application and research progress of anti-angiogenesis therapy in tumor immunotherapy.抗血管生成治疗在肿瘤免疫治疗中的应用及研究进展。
Front Immunol. 2023 Jun 2;14:1198972. doi: 10.3389/fimmu.2023.1198972. eCollection 2023.
7
Passing of Nanocarriers across the Histohematic Barriers: Current Approaches for Tumor Theranostics.纳米载体穿越组织血液屏障:肿瘤诊疗的当前方法
Nanomaterials (Basel). 2023 Mar 23;13(7):1140. doi: 10.3390/nano13071140.
8
Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.一氧化氮在增强癌症免疫疗法中的作用机会。
Pharmacol Rev. 2022 Oct;74(4):1146-1175. doi: 10.1124/pharmrev.121.000500.
9
Therapeutic polymeric nanomedicine: GSH-responsive release promotes drug release for cancer synergistic chemotherapy.治疗性聚合物纳米药物:谷胱甘肽响应性释放促进药物释放用于癌症协同化疗。
RSC Adv. 2019 Nov 15;9(64):37232-37240. doi: 10.1039/c9ra07051f. eCollection 2019 Nov 13.
10
Recent Advances of D-α-tocopherol Polyethylene Glycol 1000 Succinate Based Stimuli-responsive Nanomedicine for Cancer Treatment.基于 D-α-生育酚聚乙二醇 1000 琥珀酸酯的刺激响应性纳米医学在癌症治疗中的最新进展。
Curr Med Sci. 2020 Apr;40(2):218-231. doi: 10.1007/s11596-020-2185-1. Epub 2020 Apr 26.